Insider Transactions in Q2 2022 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
Srinivas Akkaraju Director |
BUY
Open market or private purchase
|
Indirect |
570,000
+9.94%
|
$7,980,000
$14.0 P/Share
|
|
May 25
2022
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+2.37%
|
$65,000
$13.03 P/Share
|
|
Apr 11
2022
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-45.88%
|
$75,000
$15.36 P/Share
|
|
Apr 11
2022
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.45%
|
$0
$0.35 P/Share
|
|
Apr 04
2022
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
735,873
-73.2%
|
-
|
|
Apr 04
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
25,920
+50.0%
|
-
|
|
Apr 04
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
2,468
+0.34%
|
-
|
|
Apr 04
2022
|
Versant Venture Capital Vii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
25,920
-100.0%
|
-
|
|
Apr 04
2022
|
Versant Venture Capital Vii, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
25,920
+50.0%
|
-
|
|
Apr 04
2022
|
Versant Venture Capital Vii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
709,953
-19.6%
|
-
|